We are a medical aesthetics company focused on developing and commercializing products that are used by physicians to enhance a patient's appearance. Our core product is Radiesse® dermal filler, an injectable dermal filler designed to provide long-lasting, cost-effective and safe aesthetic improvement for patients. Our clinical studies have demonstrated that RADIESSE dermal filler provides meaningful initial aesthetic correction and approximately 12 months’ duration of aesthetic improvement in many patients in some indications, resulting in high patient satisfaction. Physicians have used RADIESSE dermal filler for more than five years, and we have shipped over 1,000,000 syringes worldwide.
Our strategy is to become a worldwide leader in medical aesthetics by building on our success with RADIESSE dermal filler, gaining a market leading position in dermal fillers, enhancing the strength of our sales and marketing organizations in the United States and Europe, and obtaining regulatory approvals and commercializing new products beyond dermal fillers that enhance the practice of medical aesthetics. To expand our portfolio in medical aesthetics, we are developing several future aesthetics products, including a radiofrequency treatment to reduce nerve function in the forehead, a sclerotherapy treatment for spider veins, and a surgical adhesive for brow lifts.